By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Vifor Pharma 

Flughofstrasse 61

Glattbrugg    CH-8152  Switzerland
Phone: 41-58-8518000 Fax: 41-58-8518001



Company News
Vifor Pharma Reports Strong H1 2017 Results And Raises Guidance 8/8/2017 1:08:46 PM
Vifor Pharma Release: European Commission (EC) Approves Marketing Authorisation For Veltassa 7/21/2017 10:24:51 AM
Vifor Pharma Announces Three Outcomes Trials In Heart Failure And Iron Deficiency 7/12/2017 10:46:56 AM
Kissei Pharmaceutical Co., Ltd. To Market Avacopan In Japan For Vifor Fresenius Medical Care Renal Pharma 6/9/2017 10:04:35 AM
Vifor Pharma Release: CHMP Recommends Veltassa For The Treatment Of Hyperkalaemia In The EU 5/19/2017 8:00:35 AM
Akebia (AKBA) And Vifor Pharma Announce Exclusive License Agreement To Provide Vadadustat To Fresenius Medical Care In The U.S. Upon Vifor Pharma Approval 5/16/2017 7:45:59 AM
Akebia (AKBA), Vifor Pharma Strike $50 Million Exclusive Anemia Drug Pact 5/16/2017 6:01:46 AM
Bay Area Biotech Nabs $50 Million Cash Upfront in Partnership Expansion With Vifor Pharma 12/27/2016 7:08:46 AM
Bay Area's ChemoCentryx (CCXI) Inks $85 Million Deal With Vifor Pharma for Lead Product Candidate 5/11/2016 7:04:38 AM
Emirates Gastroenterology & Hepatology Society And Vifor Pharma Collaborate To Advance Iron Deficiency (ID) Management In UAE 12/17/2015 10:41:40 AM